2026-09-23 19:48:29 UTC#358100duplicateconfirmednews
BIVI stock news
BIVI stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire11 wire items
2026-09-23 19:35:11 UTC#358032newconfirmednews
BioVie reports positive Bezisterim data in Long COVID and Parkinson's; plans phase III FDA meetings
2026-09-15 13:48:47 UTC#314290updateconfirmednews
BioVie reports bezisterim showed significant symptom improvement and safety in Long COVID Phase II subgroup
2026-09-15 11:49:05 UTC#313372updateconfirmednews
BioVie to advance bezisterim to Phase 3 trials for Long COVID following positive subgroup data
2026-09-15 11:30:00 UTC#313273duplicateconfirmednews
BioVie Phase 2 ADDRESS-LC trial misses primary endpoints, shows subgroup benefits
2026-09-15 11:30:00 UTC#313263updateconfirmedpress release
BioVie reports subgroup benefits for bezisterim in Phase 2 Long COVID trial despite missing primary endpoint
2026-09-15 10:39:51 UTC#312971newconfirmednews
BioVie's bezisterim fails to meet primary endpoint in Phase 2 ADDRESS-LC trial for Long COVID
2026-09-08 11:42:14 UTC#280311newconfirmedpress release
BioVie requests FDA end-of-phase 2 meeting for Parkinson's program, expects feedback by year-end
2026-08-12 22:50:16 UTC#168376duplicateconfirmednews
BioVie's SUNRISE-PD Phase II trial of bezisterim shows motor and non-motor benefits
2026-08-12 19:45:12 UTC#167322newconfirmednews
BioVie's bezisterim meets primary endpoints in Phase 2 SUNRISE-PD Parkinson's trial, advancing to Phase 3
2026-07-17 21:45:00 UTC#48096newconfirmednews